The forum program included:

• Program WHO accelerating the elimination of cervical cancer in the era of the SARS-CoV-2 pandemic
• Cervical screening and diagnostics. Act now to save the future
• Benefits and challenges of primary HPV screening by home self-collection
• Transformation zone – understanding the pathogenesis of the disease in the vulnerable area of ​​the cervical epithelium
• The role of cytology, HPV testing and dual staining – experience from Croatia
• Cervical cancer prevention. Latvian experience
• CIN I – acting according to standards or according to medical experience
• CIN II – a constructive approach to decision-making
• HPV persistence. The role of vulvovaginal infections, vaginal microbiome. Does biocenosis correction reduce the incidence of CIN and cervical cancer?
• Atrophic vaginitis. How to break the cycle of problems?
• Differences in molecular HPV testing
• National guidelines for the management of benign and precancerous cervical pathology
• Creation of a national protocol for the treatment of cervical cancer
• Organ-preserving treatment in patients with invasive cervical cancer
• Extreme surgery in locally advanced and recurrent cervical cancer
• Cervical pathology in clinical cases. Multidisciplinary coworking
• Demonstration of a clinical case. Diagnosis of Cancer in situ of the cervix during hysteroscopy
• Possibilities of office hysteroscopy in the diagnosis of pathology of the vagina, cervix and cervical canal
• From preliminary to final diagnosis: modern laboratory diagnostics in endometrial pathology
• AMK. Modern possibilities for optimizing treatment tactics
• Office hysteroscopy in the diagnosis of precancer and endometrial cancer
• Protocol N 869 dated 05.05.2021 “Endometrial hyperplasia”. How it works in practice
• Modern principles of treatment of endometrial cancer. Challenges and expectations
• Endometrial cancer and reproduction. Challenges for the doctor and the patient
• Reproductive prognosis in women with a history of gynecological cancer
• Registration of pregnancy-associated cancer
• Update on views on the management of adenomyosis and uterine fibroids. We are directing the vector towards conservative treatment
• Clinical portraits of widespread endometriosis. What is the role of autoimmune diseases and the immune status of women here?
• Clinical errors in the practice of obstetrician-gynecologists and oncogynecologists.

Forum program